Why We Oppose Golden Rice
By The Stop Golden Rice Network,
Independent Science News
| 08. 07. 2020
Released on the 7th annual International Day of Protest Against Golden Rice
The push for corporate-led solutions to hunger and malnutrition is alarming. In particular, Golden Rice is now being proposed as a solution to the worsening hunger and malnutrition associated with the pandemic. Agrochemical transnationals (TNCs) and collaborating institutions such as the International Rice Research Institute (IRRI) are using concerns over food security during the pandemic to push for an industrial agricultural system that is already discredited. To quote PAN Asia Pacific:
“in the webinar “The future of food systems in Southeast Asia post-COVID19” organised by IRRI and the FAO, Jean Balie, IRRI’s head of Agri-Food Policy, said that they are “looking to increase the mineral and vitamin content in rice grains” as a response to the pandemic, alluding to renewed promotion of the genetically-modified Golden Rice, which has recently been approved for commercialization in Bangladesh and the Philippines” said PANAP.
Golden Rice projects and applications are currently underway in three countries. On December 10, 2019, the Philippines’ Dept. of Agriculture’s Bureau of Plant Industry (DA-BPI) issued a Golden Rice permit for Direct Use for Food, Feed and...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...